Kala pharmaceuticals, inc. (KALA)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
Product revenues, net

6,074

-

-

-

-

Revenue

-

-

-

0

45

Costs and expenses:
Cost of product revenues

2,008

-

-

-

-

Selling, general and administrative

65,015

35,431

10,867

-

-

Research and development

27,275

29,290

29,008

25,029

11,382

General and administrative

-

-

-

7,640

4,609

Total costs and expenses

94,298

64,721

39,875

32,669

15,991

Loss from operations

-88,224

-64,721

-39,875

-32,669

-15,946

Other income (expense):
Interest income

2,357

1,687

527

147

-

Interest expense

8,480

3,314

1,019

767

604

Loss on extinguishment of debt

-

-390

-

-

-

Change in fair value of warrant liability

-

-

1,844

-122

132

Total other expense

-6,123

-2,017

-2,336

-498

-736

Net loss

-94,347

-66,738

-42,211

-33,167

-16,682

Net loss per share—basic and diluted

-2.76

-2.49

-3.71

-28.07

-14.89

Weighted average shares outstanding—basic and diluted

34,209

26,753

11,375

1,181

1,120